Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; Gland Pharma informed that the ESOP Compensation Committee of the Board of Directors of the Company has allotted 311,800 Equity shares of Re 1 each of the Company, fully paid up, on May 5, 2021 to employees on exercise of their Stock Options (ESOP) pursuant to the company’s Employee Stock Options Scheme, 2019. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs 163,904,723 comprising of 163,904,723 Equity shares of face value Re 1 each.
The above information is a part of company’s filings submitted to BSE.
